Manufacturing site transfers

When executing manufacturing site transfers, supply of a finished medicinal product is transferred from its present location to Jubilant’s EU-GMP approved plant in Roorkee, India.

These transfers are performed while fully respecting the product specifications approved in the Marketing Authorisation. At the same time the active substance can be substituted by a non-infringing alternative, possibly a Jubilant in-house API.

Site transfers can be performed for products that are on the market, under registration, or under development.

The full project management of a site transfer is managed at Jubilant Pharmaceuticals, which includes the following aspects: pharmaceutical, technical, logistic and regulatory. We offer a competitive supply price and prepare realistic timelines for the project up to the approval by the Authorities and the delivery of the first order to the customer’s warehouse.

Why consider a site transfer?

• Jubilant’s manufacturing facilities for both active substances and finished dosage forms are state-of-the-art, EU-GMP and FDA approved
• We offer flexible purchase prices in function of the market conditions and guarantee quality and continuity of the supplies
• We take care of the full project management, allowing our customers to concentrate on their core business, improve price competitiveness and maintain market share in times of price erosion